FSE

Recce Pharmaceuticals Completes Dosing First Subjects at 15-Minute Infusion Rate in a Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Retrieved on: 
Thursday, November 9, 2023
ASX, FSE, Female, Male, Safety, Urinary tract infection, Patient, RCE, Pharmaceutical industry

SYDNEY, Australia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced it completed dosing the first healthy subjects at the highest concentration of 3,000mg within a fast infusion rate of 15-minutes in a Phase I/II trial evaluating its lead anti-infective candidate, RECCE® 327 (R327).

Key Points: 
  • SYDNEY, Australia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced it completed dosing the first healthy subjects at the highest concentration of 3,000mg within a fast infusion rate of 15-minutes in a Phase I/II trial evaluating its lead anti-infective candidate, RECCE® 327 (R327).
  • “To be dosing at twice the speed of the last cohort to 3,000mg over 15 minutes via intravenous administration is a testament to the safety and tolerability profile of R327,” said James Graham, Chief Executive Officer of Recce Pharmaceuticals.
  • “This marks another important clinical milestone for the company, as we push towards achieving R327’s potential as a first-line treatment for the millions of patients with from UTIs each year, which, if left untreated, may lead to urosepsis.”
    An independent safety committee recently unanimously concluded that R327 is safe and well tolerated in healthy male and female subjects at an infusion rate of 3,000mg via intravenous administration over 30 minutes.
  • Since the previous cohort dosed, the committee approved a faster infusion rate, double that of what was previously delivered at 30 minutes, now being delivered at 3,000mg over 15 minutes.

FREYR Battery Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 9, 2023
Technology, Batteries, Alternative Energy, Energy, Inflation Reduction Act of 2022, Policy, NYSE, U.S. Department of Energy, Office of Inspector General, Spec Racer Ford, Casting, Public expenditure, White Sands Test Center, Battery, Glencore, Longest increasing subsequence, Erongo Battery Energy Storage System, Research, Software, Participation, SAP SE, MCS, Central European, TSE, Ecosystem, Partnership, SAP, SE, Caterpillar Inc., FSE, Siemens, Nidec, U.S. Department of Defense Strategy for Operating in Cyberspace, Rationalization, Heads of terms, Electric battery, Satellite navigation device, Bank, Security (finance), Sales, Mobile phone, Risk management, Operation

FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, today reported financial results for the third quarter of 2023.

Key Points: 
  • FREYR Battery (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, today reported financial results for the third quarter of 2023.
  • Having ended 3Q 2023 with $328 million of cash and no debt, the Company expects to exit 2023 with cash of approximately $250 million after satisfying its remaining commitments and fourth quarter overhead.
  • At the end of 3Q 2023 FREYR had completed the handovers of 337 of 388 discrete commissioning and testing packages.
  • A presentation will be held today, November 9, 2023, at 8:30 am Eastern Standard Time (2:30 pm Central European Time) to discuss financial results for the third quarter 2023.

MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 8, 2023
FSE, Webcast, TSX, International, Drug

TORONTO, Nov. 8, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its third quarter financial results for the three and nine month periods ended September 30, 2023, before markets open on Tuesday, November 14, 2023.

Key Points: 
  • TORONTO, Nov. 8, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its third quarter financial results for the three and nine month periods ended September 30, 2023, before markets open on Tuesday, November 14, 2023.
  • MediPharm's executive management team will also host a conference call and audio webcast on Tuesday, November 14, 2023 at 8:30 a.m. eastern time to discuss the Company's financial results.
  • Audio Conference Call Dial in Details:
    Toll-free number: +1 (888) 330-2454 / International number: +1 (240) 789-2714
    Participants are asked to dial in approximately 15 minutes before the start of the call.
  • For those who are unable to participate on the live conference call or webcast, a replay will be available at https://www.medipharmlabs.com/investors approximately one day after completion of the call.

Scotch Creek Completes Soil Sampling Program on Miranda Project

Retrieved on: 
Wednesday, November 8, 2023
FSE, Scotch Creek, News, OTC Markets Group, Miranda, SCV, Qualified person (European Union), CSE, Rare-earth element

Vancouver, British Columbia--(Newsfile Corp. - November 8, 2023) - Scotch Creek Ventures Inc. (CSE: SCV) (FSE: 7S2) (OTC Pink: SCVFF) (the "Company") ("Scotch Creek" or the "Company") is pleased to announce the completion of a soil sampling program on their 5,360-acre Miranda project located in Jackson Valley, Nevada.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - November 8, 2023) - Scotch Creek Ventures Inc. (CSE: SCV) (FSE: 7S2) (OTC Pink: SCVFF) (the "Company") ("Scotch Creek" or the "Company") is pleased to announce the completion of a soil sampling program on their 5,360-acre Miranda project located in Jackson Valley, Nevada.
  • The program consisted of 69 sample points collected by Scotch Creeks Technical Director, Robert D. Marvin, P. Geo.
  • Scotch Creek Ventures' exploration team executed the soil sampling program, announced on October 11, 2023 (see news release ) and covered strategic locations across the Miranda project.
  • Scotch Creek Ventures will continue to build on the soil sampling program as they continue progressing exploration and development activities on the Miranda project.

Heliostar's New Parallel Panel Yields 16m Grading 11.2 g/t Gold within 147m Grading 4.1 g/t Gold at Ana Paula Project

Retrieved on: 
Wednesday, November 8, 2023
Sempra Metals Ltd v IRC, High grading, Gold, Ana Paula, Orientation, Growth, Parallel, FSE, Printed circuit board

The Company's improved understanding of the gold mineralization led to the recent recognition of a new Parallel Panel only 50 metres north of the High Grade Panel.

Key Points: 
  • The Company's improved understanding of the gold mineralization led to the recent recognition of a new Parallel Panel only 50 metres north of the High Grade Panel.
  • In hole AP-23-309, the High Grade and Parallel panels almost connect, returning 147m at 4.13g/t gold which remains open to depth.
  • Within that, the hole encountered 16.0 metres grading 11.2 g/t gold from 77.0 metres downhole in the Parallel Panel target.
  • Those include 7.0 metres grading 14.5 g/t gold from 112.4 metres downhole and 8.6 metres grading 8.70 g/t gold from 153.5 metres downhole.

Victory Square Portfolio Company Hydreight Named One of Canada’s Companies-to-Watch in Deloitte’s Technology Fast 50™ Program

Retrieved on: 
Wednesday, November 8, 2023
Yoy, Deloitte Technology Fast 500, OTC, Face, CSE, VST, Growth, City, Eye, FSE, Nursing, Video game

VANCOUVER, British Columbia, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce that portfolio company Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6) received a Companies-to-Watch award as part of the 2023 Deloitte Technology Fast 50™ program.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce that portfolio company Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6) received a Companies-to-Watch award as part of the 2023 Deloitte Technology Fast 50™ program.
  • Hydreight is a fast-growing mobile clinical network and medical platform which enables flexible at-home medical services across 50 states in the United States.
  • Shane Madden, CEO of Hydreight commented, “We are thrilled to receive a Companies-to-Watch award for 2023, from the esteemed Deloitte Technology Fast 50™ program.
  • “Congratulations to this year’s Companies-to-Watch winners,” commented Anders McKenzie, partner and national leader for the Technology Fast 50 program at Deloitte Canada.

Aduro Clean Technologies Appoints Marie Grönborg to Board of Directors

Retrieved on: 
Wednesday, November 8, 2023
ACT, Master of Science, H&M, Chemical engineering, Chemical industry, IKEA, SSAB, Acquisition, CSE, FSE, Oil, Plastic, Management, Renewable energy, Jason Puracal

in Chemical Engineering and has almost 30 years of global experience in the chemical and clean-tech industries.

Key Points: 
  • in Chemical Engineering and has almost 30 years of global experience in the chemical and clean-tech industries.
  • Before joining TreeToTextile, Ms. Grönborg was the CEO of Purac, a provider of turn-key solutions for water treatment and biogas production.
  • “I am very excited about the opportunity to join Aduro as a director of the board and genuinely look forward to contributing to realizing the potential of Aduro and its groundbreaking Hydrochemolytic technology,” commented Ms. Grönborg.
  • Her extensive experience in the chemical and clean-tech industries makes her an invaluable addition,” said Ofer Vicus, CEO of Aduro.

Hydreight Named One of Canada’s Companies-to-Watch in Deloitte’s Technology Fast 50™ Program

Retrieved on: 
Wednesday, November 8, 2023
LAS, Yoy, Deloitte Technology Fast 500, Face, NURS, Growth, City, Eye, FSE, Nursing, Video game

Shane Madden, CEO of Hydreight commented, “We are thrilled to receive a Companies-to-Watch award for 2023, from the esteemed Deloitte Technology Fast 50™ program.

Key Points: 
  • Shane Madden, CEO of Hydreight commented, “We are thrilled to receive a Companies-to-Watch award for 2023, from the esteemed Deloitte Technology Fast 50™ program.
  • We would like to thank Deloitte for their consideration and support of Hydreight and what we are building.
  • “Congratulations to this year’s Companies-to-Watch winners,” commented Anders McKenzie, partner and national leader for the Technology Fast 50 program at Deloitte Canada.
  • We look forward to keeping an eye on their progress in the months and years to come.”

Rivalry to Report Third Quarter 2023 Results on November 29

Retrieved on: 
Wednesday, November 8, 2023
FSE, Generation Z, Millennials, IGaming Business, Webcast

TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for Millennials and Gen Z, today announced details of its planned release of third quarter 2023 financial results.

Key Points: 
  • TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for Millennials and Gen Z, today announced details of its planned release of third quarter 2023 financial results.
  • The Company expects to file its Q3 2023 results the morning of Wednesday, November 29, 2023 prior to the commencement of TSXV trading.
  • Management plans to host an investor conference call that same day at 10:00 am EST to discuss the results.
  • A replay of the webcast will be archived on the Company’s website for one year.

Nickel 28 Releases Ramu Q3 2023 Operating Performance

Retrieved on: 
Wednesday, November 8, 2023
Mining, Minerals, Natural Resources, FAST marketing, Metallurgical Corporation of China, Nickel, MHP, Cobalt, Greenbriar Capital Corp, NKL, LME, FSE, COVID-19, YTD, Palladium, Copper, Uranium mining

Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC0) is pleased to provide operational results for the production quarter ending September 30, 2023 for the Company’s largest asset, being the Ramu Nickel-Cobalt (“Ramu”) integrated operation in Papua New Guinea.

Key Points: 
  • Nickel 28 Capital Corp. (“Nickel 28” or the “Company”) (TSXV: NKL) (FSE: 3JC0) is pleased to provide operational results for the production quarter ending September 30, 2023 for the Company’s largest asset, being the Ramu Nickel-Cobalt (“Ramu”) integrated operation in Papua New Guinea.
  • Ramu Q3 2023 production of 8,979 tonnes of contained nickel in mixed hydroxide precipitate (“MHP”), compared to 8,939 tonnes in Q3 2022.
  • Ramu Q3 2023 production of 851 tonnes of contained cobalt in MHP, compared to 759 tonnes in Q3 2022.
  • Ramu Q3 2023 nickel sales of 8,832 tonnes of contained nickel, compared to 13,676 tonnes in Q3 2022.